Literature DB >> 22828711

Visuo-oculomotor deficiency at early-stage idiopathic scoliosis in adolescent girls.

Alexis Lion1, Thierry Haumont, Gérome C Gauchard, Sylvette R Wiener-Vacher, Pierre Lascombes, Philippe P Perrin.   

Abstract

STUDY
DESIGN: Cross-sectional study.
OBJECTIVE: To determine whether adolescent idiopathic scoliosis (AIS) at onset is associated with oculomotor dysfunction and whether these oculomotor anomalies are correlated to the amplitude of the spine deformation. SUMMARY OF BACKGROUND DATA: AIS is related to abnormalities of postural control. To date, few studies have focused on visuo-oculomotor and vestibulo-ocular functions at early-stage AIS.
METHODS: Fifty-three adolescent girls were diagnosed with AIS (mean age: 11.6 ± 2.1 yr) on clinical and radiological criteria (mean Cobb angle: 14.8° ± 5.0°). Visuo-oculomotor and vestibulo-ocular functions were studied with video-oculography, including saccades, smooth pursuit, caloric test, and pendular rotation, with visual vestibular ocular reflex and vestibulo-ocular reflex sequences. Two patient groups were defined according to the mean Cobb angle: group 1 included 29 patients with a Cobb angle from 5° to 14° and group 2 included 24 patients with a Cobb angle from 15° to 25°.
RESULTS: The group 2 showed different saccade characteristics than group 1: higher latencies for saccade sequences characterized by temporal uncertainty and predictive direction; lower velocity regardless of the type of the saccades. No difference was observed for saccadic accuracy and smooth-pursuit gain. For the visual vestibular ocular reflex, group 2 showed lower total maximal slow-phase velocity than group 1, whereas the vestibulo-ocular reflex (tested in dark) did not differ between groups. No difference was observed concerning the caloric vestibular test.
CONCLUSION: Patients with a Cobb angle of 15° or more presented normal vestibulo-ocular responses but altered visuo-oculomotor functions, especially for the saccadic latency and velocity. This could be the result of a dysfunction of oculomotor pathways at cerebellar and/or brainstem level. These central disorders may be incriminated in the development of AIS.

Entities:  

Mesh:

Year:  2013        PMID: 22828711     DOI: 10.1097/BRS.0b013e31826a3b05

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

1.  Visuo-oculomotor skills related to the visual demands of sporting environments.

Authors:  Hadrien Ceyte; Alexis Lion; Sébastien Caudron; Philippe Perrin; Gérome C Gauchard
Journal:  Exp Brain Res       Date:  2016-10-04       Impact factor: 1.972

2.  Eye-hand laterality and right thoracic idiopathic scoliosis.

Authors:  Jean-François Catanzariti; Marc-Alexandre Guyot; Olivier Agnani; Samantha Demaille; Elisabeth Kolanowski; Cécile Donze
Journal:  Eur Spine J       Date:  2014-03-17       Impact factor: 3.134

Review 3.  Idiopathic scoliosis and the vestibular system.

Authors:  Ammar H Hawasli; Timothy E Hullar; Ian G Dorward
Journal:  Eur Spine J       Date:  2014-11-28       Impact factor: 3.134

4.  Evaluation of motion sickness susceptibility by motion sickness susceptibility questionnaire in adolescents with idiopathic scoliosis: a case-control study.

Authors:  Jean-Francois Catanzariti; Marc-Alexandre Guyot; Caroline Massot; Hichem Khenioui; Olivier Agnani; Cécile Donzé
Journal:  Eur Spine J       Date:  2015-06-16       Impact factor: 3.134

5.  Postural control in Chiari I malformation: protocol for a paediatric prospective, observational cohort - potential role of posturography for surgical indication.

Authors:  Irene Stella; Thomas Remen; Arthur Petel; Anthony Joud; Olivier Klein; Philippe Perrin
Journal:  BMJ Open       Date:  2022-05-12       Impact factor: 3.006

6.  The Vestibular-Evoked Postural Response of Adolescents with Idiopathic Scoliosis Is Altered.

Authors:  Jean-Philippe Pialasse; Martin Descarreaux; Pierre Mercier; Jean Blouin; Martin Simoneau
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.